ROIV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.90%

Insider Buying (Last 12 Months): $336,900,200.00

Insider Selling (Last 12 Months): $80,108,208.08

Roivant Sciences Insider Trading History Chart

Roivant Sciences Share Price & Price History

^$11.29

▲ +0.1 (0.89%)

As of 04/29/2025 05:00 PM ET

Days: 30 | 90 | 365

Roivant Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/21/2025	Eric Venker	COO	Sell	100,000	$10.22	$1,022,000.00	1,116,345
3/24/2025	Eric Venker	COO	Sell	434,478	$10.82	$4,701,051.96	1,127,290
3/20/2025	Eric Venker	COO	Sell	315,522	$11.06	$3,489,673.32	959,457
2/20/2025	Eric Venker	COO	Sell	100,000	$10.65	$1,065,000.00	896,869
2/13/2025	Eric Venker	COO	Sell	218,041	$10.42	$2,271,987.22	896,869
2/13/2025	Rakhi Kumar	CAO	Sell	227,500	$10.43	$2,372,825.00	163,264
1/21/2025	Eric Venker	COO	Sell	100,000	$11.28	$1,128,000.00	732,294
1/13/2025	Sciences Ltd. Roivant	Director	Buy	16,845,010	$20.00	$336,900,200.00	96,650,341
12/30/2024	Eric Venker	COO	Sell	177,704	$11.54	$2,050,704.16	740,976
12/27/2024	Eric Venker	COO	Sell	176,900	$11.82	$2,090,958.00	668,680
12/26/2024	Mayukh Sukhatme	CIO	Sell	689,495	$12.01	$8,280,834.95	18,836,547
12/24/2024	Mayukh Sukhatme	CIO	Sell	185,946	$12.00	$2,231,352.00	18,836,547
12/20/2024	Eric Venker	COO	Sell	100,000	$11.49	$1,149,000.00	595,580
12/18/2024	Mayukh Sukhatme	CIO	Sell	412,584	$12.05	$4,971,637.20	18,836,547
11/20/2024	Eric Venker	COO	Sell	100,000	$11.32	$1,132,000.00	606,525
10/21/2024	Eric Venker	COO	Sell	100,000	$11.65	$1,165,000.00	617,470
9/26/2024	Financial Lp Qvt	Director	Sell	876,000	$11.82	$10,354,320.00	22,179,358
9/24/2024	Keith S. Manchester	Director	Sell	368,052	$11.62	$4,276,764.24	1,412,126
9/23/2024	Matthew Gline	CEO	Sell	1,983,257	$11.79	$23,382,600.03	17,870,543
9/23/2024	Rakhi Kumar	CAO	Sell	250,000	$11.89	$2,972,500.00	209,322
2/9/2024	Eric Venker	COO	Sell	96,950	$10.92	$1,058,694.00	532,207
1/2/2024	Vivek Ramaswamy	Major Shareholder	Sell	3,000,000	$11.05	$33,150,000.00	51,929,426
10/5/2023	Eric Venker	COO	Sell	153,027	$10.11	$1,547,102.97	595,397
10/2/2023	Eric Venker	COO	Sell	440,752	$10.80	$4,760,121.60	595,397
10/2/2023	Sciences Ltd. Roivant	Director	Buy	1,526,316	$38.00	$58,000,008.00	79,805,331
9/28/2023	Keith S. Manchester	Director	Sell	6,896,144	$11.55	$79,650,463.20	5,023,787
9/28/2023	Svf Investments (Uk) Ltd	Major Shareholder	Sell	10,000,000	$12.60	$126,000,000.00	73,031,667
9/27/2023	Eric Venker	COO	Sell	500,000	$13.02	$6,510,000.00	595,397
9/8/2023	Eric Venker	COO	Sell	106,430	$12.19	$1,297,381.70	611,813
9/8/2023	Rakhi Kumar	CAO	Sell	99,350	$12.18	$1,210,083.00	197,950
9/6/2023	Eric Venker	COO	Sell	5,926	$11.85	$70,223.10	611,813
9/5/2023	Rakhi Kumar	CAO	Sell	1,724	$12.00	$20,688.00	197,950
9/1/2023	Eric Venker	COO	Sell	14,763	$11.90	$175,679.70	611,813
8/14/2023	Eric Venker	COO	Sell	59,811	$11.89	$711,152.79	627,918
8/3/2023	Rakhi Kumar	CAO	Sell	3,681	$12.00	$44,172.00	199,328
8/2/2023	Eric Venker	COO	Sell	16,397	$11.86	$194,468.42	627,918
8/1/2023	Rakhi Kumar	CAO	Sell	336	$12.00	$4,032.00	199,328
7/31/2023	Eric Venker	COO	Sell	117,372	$11.91	$1,397,900.52	627,918
7/26/2023	Eric Venker	COO	Sell	73,568	$10.91	$802,626.88	627,918
7/24/2023	Eric Venker	COO	Sell	33,081	$10.93	$361,575.33	644,215
7/21/2023	Eric Venker	COO	Sell	181,998	$11.13	$2,025,637.74	644,215
7/18/2023	Rakhi Kumar	CAO	Sell	100	$12.00	$1,200.00	82,128
7/14/2023	Rakhi Kumar	CAO	Sell	535	$12.00	$6,420.00	82,128
6/22/2023	Global Investors Lp Viking	Major Shareholder	Sell	13,000,000	$9.90	$128,700,000.00	641,010
6/9/2023	Eric Venker	COO	Sell	299,384	$9.91	$2,966,895.44	660,097
6/9/2023	Rakhi Kumar	CAO	Sell	43,893	$9.93	$435,857.49	198,582
6/7/2023	Eric Venker	COO	Sell	201	$9.85	$1,979.85	660,097
5/23/2023	Eric Venker	COO	Sell	415	$9.85	$4,087.75	675,768
5/8/2023	Eric Venker	COO	Sell	61,206	$8.93	$546,569.58	675,768
5/4/2023	Eric Venker	COO	Sell	88,838	$8.30	$737,355.40	675,768
5/2/2023	Eric Venker	COO	Sell	109,074	$8.29	$904,223.46	675,768
5/2/2023	Rakhi Kumar	CAO	Sell	15,517	$8.42	$130,653.14	200,139
4/28/2023	Rakhi Kumar	CAO	Sell	71,989	$8.47	$609,746.83	200,139
4/27/2023	Eric Venker	COO	Sell	73,514	$8.51	$625,604.14	675,768
4/26/2023	Rakhi Kumar	CAO	Sell	87,830	$8.68	$762,364.40	200,139
3/20/2023	Svf Investments (Uk) Ltd	Major Shareholder	Sell	12,000,000	$8.00	$96,000,000.00	83,031,667
3/1/2023	Richard Pulik	CFO	Sell	1,912	$8.08	$15,448.96	223,347
2/22/2023	Vivek Ramaswamy	Director	Sell	4,000,000	$7.95	$31,800,000.00	54,409,211
1/5/2023	Eric Venker	COO	Sell	24,037	$8.02	$192,776.74	729,429
1/3/2023	Eric Venker	COO	Sell	95,484	$7.32	$698,942.88	753,466
12/8/2022	Eric Venker	COO	Sell	11,729	$7.00	$82,103.00	1,022,118
11/10/2022	Financial Lp Qvt	Director	Sell	5,656,081	$4.75	$26,866,384.75	5,470,181
11/10/2022	Pharma Technologies Ltd Dexcel	Major Shareholder	Buy	4,000,000	$5.00	$20,000,000.00	102,849,443
10/25/2022	Eric Venker	COO	Sell	15,922	$4.40	$70,056.80	1,049,850
10/25/2022	Matthew Gline	CEO	Sell	19,276	$4.40	$84,814.40	1,164,009
10/25/2022	Rakhi Kumar	CAO	Sell	1,588	$4.40	$6,987.20	139,354
10/6/2022	Sciences Ltd. Roivant	Major Shareholder	Buy	416,667	$6.00	$2,500,002.00	73,805,331
9/23/2022	Eric Venker	COO	Sell	17,392	$3.07	$53,393.44	1,065,772
9/23/2022	Matthew Gline	CEO	Sell	21,053	$3.07	$64,632.71	1,183,285
9/23/2022	Rakhi Kumar	CAO	Sell	1,741	$3.07	$5,344.87	140,942
8/24/2022	Eric Venker	COO	Sell	16,530	$3.71	$61,326.30	1,083,164
8/24/2022	Matthew Gline	CEO	Sell	20,009	$3.71	$74,233.39	1,204,338
8/24/2022	Rakhi Kumar	CAO	Sell	1,652	$3.71	$6,128.92	142,683
7/25/2022	Eric Venker	COO	Sell	16,896	$4.33	$73,159.68	1,099,694
7/25/2022	Matthew Gline	CEO	Sell	20,455	$4.33	$88,570.15	1,224,347
7/25/2022	Rakhi Kumar	CAO	Sell	1,686	$4.33	$7,300.38	144,335
6/23/2022	Eric Venker	COO	Sell	16,402	$4.34	$71,184.68	1,116,590
6/23/2022	Matthew Gline	CEO	Sell	19,855	$4.34	$86,170.70	1,244,802
6/23/2022	Rakhi Kumar	CAO	Sell	1,635	$4.34	$7,095.90	146,021
5/20/2022	Eric Venker	COO	Sell	136,421	$3.70	$504,757.70	1,132,992
5/20/2022	Matthew Gline	CEO	Sell	139,791	$3.70	$517,226.70	1,264,657
5/20/2022	Rakhi Kumar	CAO	Sell	12,127	$3.70	$44,869.90	147,656

See Full Table

SEC Filings (Institutional Ownership Changes) for Roivant Sciences (NASDAQ:ROIV)

64.76% of Roivant Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Roivant Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/29/2025	Bank of New York Mellon Corp	4,000,181	$40.36M	0.0%	+16.3%	0.561%
4/29/2025	GF Fund Management CO. LTD.	18,641	$0.19M	0.0%	+22.0%	0.003%
4/28/2025	Principal Financial Group Inc.	968,639	$9.77M	0.0%	-1.6%	0.136%
4/28/2025	Oregon Public Employees Retirement Fund	85,533	$0.86M	0.0%	-2.2%	0.012%
4/28/2025	Teacher Retirement System of Texas	98,022	$0.99M	0.0%	-10.5%	0.014%
4/28/2025	DAVENPORT & Co LLC	21,700	$0.22M	0.0%	-86.4%	0.003%
4/28/2025	Elevate Capital Advisors LLC	177,394	$1.79M	1.7%	-0.8%	0.025%
4/25/2025	New York State Teachers Retirement System	221,721	$2.24M	0.0%	-12.8%	0.031%
4/25/2025	Amalgamated Bank	192,643	$1.94M	0.0%	-5.7%	0.027%
4/23/2025	Penn Davis Mcfarland Inc.	1,707,232	$17.23M	2.0%	+3.5%	0.239%
4/22/2025	Cambridge Investment Research Advisors Inc.	46,027	$0.46M	0.0%	-3.6%	0.006%
4/21/2025	Retirement Systems of Alabama	512,402	$5.17M	0.0%	-1.9%	0.072%
4/17/2025	FNY Investment Advisers LLC	9,536	$96K	0.1%	-17.2%	0.001%
4/15/2025	Fifth Third Bancorp	5,118	$52K	0.0%	+59.3%	0.001%
4/15/2025	Assenagon Asset Management S.A.	56,537	$0.57M	0.0%	N/A	0.008%
4/15/2025	GAMMA Investing LLC	6,493	$66K	0.0%	+83.0%	0.001%
4/14/2025	Yousif Capital Management LLC	148,891	$1.50M	0.0%	-4.7%	0.021%
4/14/2025	UMB Bank n.a.	4,143	$42K	0.0%	+112.7%	0.001%
4/8/2025	Rhumbline Advisers	1,057,199	$10.67M	0.0%	-1.7%	0.148%
4/8/2025	Parallel Advisors LLC	2,485	$25K	0.0%	+80.5%	0.000%
4/7/2025	GAMMA Investing LLC	65,514	$6.49M	0.0%	+1,746.5%	0.009%
3/18/2025	California State Teachers Retirement System	391,703	$4.63M	0.0%	+10.7%	0.055%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	16,400	$0.19M	0.0%	N/A	0.002%
2/27/2025	Jefferies Financial Group Inc.	40,000	$0.47M	0.0%	N/A	0.006%
2/19/2025	GF Fund Management CO. LTD.	15,285	$0.18M	0.0%	N/A	0.002%
2/19/2025	Public Employees Retirement System of Ohio	146,129	$1.73M	0.0%	-5.4%	0.020%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	2,411,466	$28.53M	0.0%	+4.5%	0.331%
2/17/2025	Woodline Partners LP	6,131,948	$72.54M	0.5%	-29.4%	0.842%
2/17/2025	Zimmer Partners LP	252,900	$2.99M	0.1%	N/A	0.035%
2/17/2025	Vestal Point Capital LP	1,250,000	$14.79M	0.9%	N/A	0.172%
2/17/2025	Vident Advisory LLC	32,039	$0.38M	0.0%	+98.7%	0.004%
2/17/2025	Tyro Capital Management LLC	2,108,283	$24.94M	8.2%	+20.1%	0.290%
2/17/2025	Stempoint Capital LP	2,712,778	$32.09M	8.0%	-2.1%	0.373%
2/17/2025	Rafferty Asset Management LLC	722,429	$8.55M	0.0%	+8.4%	0.099%
2/17/2025	PointState Capital LP	3,297,449	$39.01M	0.7%	-19.7%	0.453%
2/17/2025	ProShare Advisors LLC	54,584	$0.65M	0.0%	-13.0%	0.007%
2/17/2025	Prosight Management LP	1,500,000	$17.75M	4.9%	-12.9%	0.206%
2/17/2025	Patient Square Capital LP	12,480,000	$147.64M	55.2%	+2.1%	1.714%
2/17/2025	Nomura Holdings Inc.	56,989	$0.67M	0.0%	+8.6%	0.008%
2/17/2025	Nuveen Asset Management LLC	3,013,533	$35.65M	0.0%	-5.4%	0.414%
2/17/2025	OMERS ADMINISTRATION Corp	50,800	$0.60M	0.0%	-50.0%	0.007%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	179,266	$2.12M	0.2%	+22.0%	0.025%
2/17/2025	Maven Securities LTD	75,000	$0.89M	0.0%	-81.3%	0.010%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	28,374	$0.32M	0.0%	-66.2%	0.004%
2/17/2025	Lionshead Wealth Management LLC	10,000	$0.12M	0.1%	N/A	0.001%
2/17/2025	Jefferies Financial Group Inc.	40,000	$0.47M	0.0%	N/A	0.005%
2/17/2025	Guardian Wealth Advisors LLC NC	12,923	$0.15M	0.0%	N/A	0.002%
2/17/2025	DME Capital Management LP	5,271,067	$62.36M	3.2%	-0.7%	0.724%
2/17/2025	Caption Management LLC	150,338	$1.78M	0.0%	+1,112.4%	0.021%
2/17/2025	Baker BROS. Advisors LP	3,767,773	$44.57M	0.5%	+34.6%	0.518%
2/17/2025	Bellevue Group AG	24,000	$0.28M	0.0%	N/A	0.003%
2/17/2025	Bank of America Corp DE	1,718,269	$20.33M	0.0%	-19.5%	0.236%
2/17/2025	BNP Paribas Financial Markets	468,010	$5.54M	0.0%	N/A	0.064%
2/17/2025	Ameriprise Financial Inc.	454,082	$5.37M	0.0%	-1.2%	0.062%
2/14/2025	PDT Partners LLC	508,431	$6.02M	0.5%	+27.4%	0.070%
2/14/2025	Schonfeld Strategic Advisors LLC	71,400	$0.85M	0.0%	-79.9%	0.010%
2/14/2025	TOMS Capital Investment Management LP	5,885,000	$69.62M	2.5%	+46.6%	0.808%
2/14/2025	Northern Trust Corp	3,448,082	$40.79M	0.0%	+23.3%	0.474%
2/14/2025	The Manufacturers Life Insurance Company	338,013	$4M	0.0%	-5.2%	0.046%
2/14/2025	Virtus ETF Advisers LLC	29,432	$0.35M	0.1%	-3.4%	0.004%
2/14/2025	Gilder Gagnon Howe & Co. LLC	1,162,986	$13.76M	0.1%	N/A	0.160%
2/14/2025	Two Seas Capital LP	10,167,807	$120.29M	9.5%	+4.6%	1.397%
2/14/2025	Credit Industriel ET Commercial	150,000	$1.77M	0.2%	N/A	0.021%
2/14/2025	Voya Investment Management LLC	51,668	$0.61M	0.0%	-6.6%	0.007%
2/14/2025	Integrated Wealth Concepts LLC	288,101	$3.41M	0.0%	+16.9%	0.040%
2/14/2025	Adage Capital Partners GP L.L.C.	5,719,983	$67.67M	0.1%	-0.6%	0.786%
2/14/2025	Syon Capital LLC	22,814	$0.27M	0.0%	N/A	0.003%
2/14/2025	Price T Rowe Associates Inc. MD	248,264	$2.94M	0.0%	-9.3%	0.034%
2/14/2025	BlackBarn Capital Partners LP	4,125,000	$48.80M	2.7%	+3.1%	0.567%
2/14/2025	State of Tennessee Department of Treasury	131,223	$1.55M	0.0%	-2.7%	0.018%
2/14/2025	Teachers Retirement System of The State of Kentucky	107,740	$1.28M	0.0%	-11.6%	0.015%
2/14/2025	Tower Research Capital LLC TRC	63,458	$0.75M	0.0%	+816.5%	0.009%
2/14/2025	MetLife Investment Management LLC	242,037	$2.86M	0.0%	+7.4%	0.033%
2/14/2025	Dimensional Fund Advisors LP	131,314	$1.55M	0.0%	-35.3%	0.018%
2/14/2025	First Trust Advisors LP	2,445,396	$28.93M	0.0%	-18.7%	0.336%
2/13/2025	Marshall Wace LLP	2,946,954	$34.86M	0.0%	+104.4%	0.405%
2/13/2025	PEAK6 LLC	30,000	$0.36M	0.0%	N/A	0.004%
2/13/2025	Jump Financial LLC	11,417	$0.14M	0.0%	N/A	0.002%
2/13/2025	Ontario Teachers Pension Plan Board	33,284	$0.39M	0.0%	N/A	0.005%
2/13/2025	XTX Topco Ltd	34,972	$0.41M	0.0%	-37.0%	0.005%
2/13/2025	Mariner LLC	105,972	$1.25M	0.0%	+23.7%	0.015%
2/13/2025	Barclays PLC	569,892	$6.74M	0.0%	+24.0%	0.078%
2/13/2025	Summit Investment Advisors Inc.	86,025	$1.02M	0.9%	-3.9%	0.012%
2/13/2025	Townsquare Capital LLC	11,961	$0.14M	0.0%	N/A	0.002%
2/13/2025	Sterling Capital Management LLC	25,212	$0.30M	0.0%	+56.1%	0.003%
2/13/2025	Covestor Ltd	20,634	$0.25M	0.2%	+7.5%	0.003%
2/13/2025	Kennedy Capital Management LLC	52,908	$0.63M	0.0%	+22.7%	0.007%
2/13/2025	Treasurer of the State of North Carolina	187,047	$2.21M	0.0%	+0.6%	0.026%
2/13/2025	Jones Road Capital Management L.P.	10,000	$0.12M	0.1%	N/A	0.001%
2/13/2025	Raymond James Financial Inc.	84,091	$1M	0.0%	N/A	0.012%
2/13/2025	Legal & General Group Plc	602,858	$7.13M	0.0%	-6.0%	0.083%
2/13/2025	Invesco Ltd.	9,515,058	$112.56M	0.0%	+49.7%	1.307%
2/13/2025	ADAR1 Capital Management LLC	3,508,694	$41.51M	8.3%	+16.0%	0.482%
2/13/2025	Bank of Montreal Can	48,026	$0.57M	0.0%	+20.2%	0.007%
2/13/2025	FMR LLC	49,301,583	$583.24M	0.0%	+0.3%	6.773%
2/13/2025	Federated Hermes Inc.	29,571	$0.35M	0.0%	-60.4%	0.004%
2/13/2025	Aster Capital Management DIFC Ltd	3,261	$39K	0.0%	N/A	0.000%
2/13/2025	Russell Investments Group Ltd.	2,355	$28K	0.0%	+478.6%	0.000%
2/13/2025	Envestnet Asset Management Inc.	26,921	$0.32M	0.0%	N/A	0.004%
2/13/2025	Wells Fargo & Company MN	7,501	$89K	0.0%	+84.1%	0.001%

Data available starting January 2016

See Full Table

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It develops VTAMA, a novel topical for the treatment of psoriasis and atopic dermatitis; batoclimab and IMVT-1402, the fully human monoclonal antibodies targeting the neonatal Fc receptor across various IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody for ulcerative colitis and Crohn's disease. The company was founded in 2014 and is based in London, the United Kingdom.

Today's Range

Now: $11.29

$11.09

$11.40

50 Day Range

MA: $10.35

$9.08

$11.19

52 Week Range

Now: $11.29

$8.73

$13.06

Volume

5,275,979 shs

Average Volume

5,472,618 shs

Market Capitalization

$8.06 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

Who are the company insiders with the largest holdings of Roivant Sciences?: Roivant Sciences' top insider shareholders include:
Sciences Ltd Roivant (Director)
Svf Investments (Uk) Ltd (Major Shareholder)
Vivek Ramaswamy (Major Shareholder)
Financial Lp Qvt (Director)
Mayukh Sukhatme (CIO)
Matthew Gline (CEO)
Keith S Manchester (Director)
Eric Venker (COO)
Global Investors Lp Viking (Major Shareholder)
Rakhi Kumar (CAO)
Learn More about top insider investors at Roivant Sciences.
Who are the major institutional investors of Roivant Sciences?: Roivant Sciences' top institutional investors include:
Bank of New York Mellon Corp — 0.56%
Penn Davis Mcfarland Inc. — 0.24%
Rhumbline Advisers — 0.15%
Principal Financial Group Inc. — 0.14%
Retirement Systems of Alabama — 0.07%
New York State Teachers Retirement System — 0.03%
Learn More about top institutional investors of Roivant Sciences stock.
Which major investors are selling Roivant Sciences stock?: During the previous quarter, ROIV stock was sold by these institutional investors:
DAVENPORT & Co LLC
New York State Teachers Retirement System
Rhumbline Advisers
Principal Financial Group Inc.
Amalgamated Bank
Teacher Retirement System of Texas
Retirement Systems of Alabama
Yousif Capital Management LLC
Within the last year, company insiders that have sold Roivant Sciences company stock include:
Sciences Ltd Roivant (Director)
Svf Investments (Uk) Ltd (Major Shareholder)
Vivek Ramaswamy (Major Shareholder)
Financial Lp Qvt (Director)
Mayukh Sukhatme (CIO)
Matthew Gline (CEO)
Learn More investors selling Roivant Sciences stock.
Which major investors are buying Roivant Sciences stock?: During the last quarter, ROIV stock was bought by institutional investors including:
Bank of New York Mellon Corp
GAMMA Investing LLC
Penn Davis Mcfarland Inc.
Assenagon Asset Management S.A.
GF Fund Management CO. LTD.
GAMMA Investing LLC
UMB Bank n.a.
Fifth Third Bancorp